ZMB Enterprises, LLC (distributor) Addall XL (30 capsules) — tested by FDA laboratory analysis

Addall XL (30 capsules) (ZMB Enterprises, LLC (distributor)), tested by FDA laboratory analysis.
This is an independent test. Whoever paid for it had no interest in the answer.

Analyte	Found
2-amino-6-methylheptane (DMHA)	detected, no quantity published
1,4-DMAA (1,4-dimethylamylamine)	detected, no quantity published

FDA alert of 2026-04-03: the capsules contain 2-amino-6-methylheptane (DMHA), which FDA calls an unlawful ingredient in dietary supplements, as well as undeclared 1,4-DMAA. FDA informed the distributor of the test results on 2026-01-06 and recommended a recall; the firm declined to recall this product. No quantities were published.

Source: Regulator finding

Measured by or for a regulator and published in a warning letter, advisory or recall. Note the selection: an agency tests what it already suspects, so these findings say what was wrong with the products that drew attention, and nothing about the ones that did not.

Report: www.fda.gov

This entry records one test of one sample. It is not a statement about any other batch, and it is not a safety assessment.